Clinical Trials Logo
  1. Home
  2. Cirrhosis, Liver
  3. NCT05729438
  4. Details
NCT05729438 Clinical Trial

Nutritional Assesment in Patients With Cirrhosis

Cirrhosis, Liver Clinical Trial

Official title:
Nutritional Assesment in Patients With Cirrhosis

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05729438
Other study ID # 559
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2023
Est. completion date December 31, 2024

Study information
Verified date February 2023
Source SUUMC Central Military Hospital Dr Carol Davila
Contact SANDICA BUCURICA
Phone 0213193051
Email bucuricasandy@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to evaluated nutritional status in patiets with cirrhosis

Recruitment information / eligibility
Status Recruiting
Enrollment 50
Est. completion date December 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - signed informed consent - age >18, <75 years old - hepatic cirrhosis diagnosis Exclusion Criteria: - refuse to participate/to give consent - presence of musculo-skeletal disease previous diagnosed, neuropathic diseases, malignancy

Study Design

Related Conditions & MeSH terms

Intervention

Dietary Supplement:
• BCAA
status of nutrition evaluation after 3 months of BCAA

Locations
Country Name City State
Romania Suumc Bucure?ti Bucure?ti - Sector1

Sponsors (1)
Lead Sponsor Collaborator
SUUMC Central Military Hospital Dr Carol Davila

Country where clinical trial is conducted

Romania, 

Outcome
Type Measure Description Time frame Safety issue
Primary muscle mass improvement 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05793983 - S100A8/A9 and Innate Immunity in Liver Disease
Completed NCT04604860 - Use of EL-FIT App to Promote Physical Activity N/A
Recruiting NCT05928624 - A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients N/A
Active, not recruiting NCT01438970 - Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function Phase 2
Recruiting NCT05998330 - LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease N/A
Completed NCT04581369 - Cirrhosis Medical Home N/A
Withdrawn NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Recruiting NCT04588077 - Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis Phase 4
Recruiting NCT05538962 - Longitudinal Monitoring of Inflammation in Cirrhosis N/A
Completed NCT04082780 - Rifamycin in Minimal Hepatic Encephalopathy Phase 2
Completed NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Active, not recruiting NCT03736265 - Carvedilol for Prevention of Esophageal Varices Progression N/A
Recruiting NCT04530760 - Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical Ventilation
Recruiting NCT05093218 - Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease. N/A
Recruiting NCT03437876 - Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis N/A
Recruiting NCT05604274 - Longitudinal Monitoring of Stool Characteristics
Recruiting NCT04867954 - Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Completed NCT04643795 - Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects Phase 1
Active, not recruiting NCT02344680 - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Completed NCT04121520 - Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey